Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection.

HIV-1 induces an uncontrolled inflammatory response of several immune components, such as inflammasomes. These molecular complexes, associated with Toll-like receptor (TLR) activity, induce the maturation and release of IL-1 and IL-18 and eventually induce pyroptosis. It has been previously demonstr...

Full description

Autores:
Feria-Garzón, Manuel G
Rugeles, María T
Hernández López, Juan Carlos
Lujan, Jorge A
Taborda, Natalia A
Tipo de recurso:
Article of journal
Fecha de publicación:
2019
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/42850
Acceso en línea:
https://doi.org/10.5944/rppc.vol.21.num.3.2016.15711
https://www.scielo.br/scielo.php?pid=S0103-84782012000400017&script=sci_abstract
https://hdl.handle.net/20.500.12494/42850
Palabra clave:
HIV
inflammasomes
inflammation
sulfasalazine
toll-like receptors
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
Description
Summary:HIV-1 induces an uncontrolled inflammatory response of several immune components, such as inflammasomes. These molecular complexes, associated with Toll-like receptor (TLR) activity, induce the maturation and release of IL-1 and IL-18 and eventually induce pyroptosis. It has been previously demonstrated that HIV induces inflammasome activation, which is significantly lower in the gastrointestinal tissue and blood from people living with HIV-1 with spontaneous control of viral replication. Therefore, immunomodulatory agents could be useful in improving HIV prognosis.